KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Acquisitions (2017 - 2025)

Chemed (CHE) has 13 years of Acquisitions data on record, last reported at $225000.0 in Q1 2025.

  • For Q1 2025, Acquisitions fell 96.92% year-over-year to $225000.0; the TTM value through Dec 2025 reached $225000.0, down 99.77%, while the annual FY2025 figure was $225000.0, 99.77% down from the prior year.
  • Acquisitions reached $225000.0 in Q1 2025 per CHE's latest filing, down from $5.1 million in the prior quarter.
  • Across five years, Acquisitions topped out at $85.0 million in Q2 2024 and bottomed at $225000.0 in Q1 2025.
  • Average Acquisitions over 4 years is $13.1 million, with a median of $2.7 million recorded in 2022.
  • Peak YoY movement for Acquisitions: surged 836.29% in 2023, then plummeted 96.92% in 2025.
  • A 4-year view of Acquisitions shows it stood at $1.5 million in 2022, then skyrocketed by 148.42% to $3.7 million in 2023, then surged by 38.25% to $5.1 million in 2024, then tumbled by 95.59% to $225000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Acquisitions were $225000.0 in Q1 2025, $5.1 million in Q3 2024, and $85.0 million in Q2 2024.